This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FDA's Scientific Conclusions Should Prompt Agency To Act Quickly To Ban Menthol Cigarettes

WASHINGTON, July 23, 2013 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids:

(Logo: http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO)

The Food and Drug Administration's strong scientific conclusions today regarding the harmful impact of menthol cigarettes on the nation's health should prompt the FDA to move as quickly as possible to ban menthol cigarettes in the United States.

The FDA today took the first step in the regulatory process by inviting public comment to inform its decisions about what action to take regarding menthol cigarettes and announcing that it is funding additional research relevant to regulating menthol cigarettes.  It is critical that these actions be part of a serious and expeditious regulatory process that leads to a ban on menthol cigarettes and not part of an effort to delay action.  The key is not what the FDA announced today, but how quickly the agency acts to develop a formal rule banning menthol cigarettes based on the powerful scientific evidence in the report it released today.

After an exhaustive review of the scientific evidence, the FDA released a 153-page report that reached three key conclusions regarding the health impact of menthol cigarettes. It found that menthol cigarettes lead to 1) increased smoking initiation among youth and young adults; 2) greater addiction; and 3) decreased success in quitting smoking. "These findings, combined with the evidence indicating that menthol's cooling and anesthetic properties can reduce the harshness of cigarette smoke and the evidence indicating that menthol cigarettes are marketed as a smoother alternative to nonmenthol cigarettes, make it likely that menthol cigarettes pose a public health risk above that seen with nonmenthol cigarettes," the FDA's report concluded.

The FDA's report independently affirms the findings of the agency's Tobacco Products Scientific Advisory Committee, which in March 2011 issued a report that concluded, "Removal of menthol cigarettes from the marketplace would benefit public health in the United States." 

We now have two exhaustive scientific reports that leave no doubt that menthol cigarettes have a profound adverse impact on public health in the United States, resulting in more smoking and more death and disease from tobacco use.  The FDA has an obligation to act on this scientific evidence and move quickly to ban menthol cigarettes in the U.S.  These reports provide more than adequate scientific evidence for the FDA to take immediate action.

The FDA should also move forward quickly with its plans to conduct a youth education campaign focused on preventing and reducing tobacco use, including menthol cigarettes.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs